Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07620327Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in hypotension comparing Placebo with Push dose adrenaline (2 arms). Primary endpoint: Peri-intubation hypotension at 60 months. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07620327.